These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28251028)

  • 1. Empyema due to Streptococcus Pneumoniae Serotype 9V in a Child Immunized with 13-Valent Conjugated Pneumococcal Vaccine.
    Sütçü M; Aktürk H; Karagözlü F; Somer A; Gürler N; Salman N
    Balkan Med J; 2017 Jan; 34(1):74-77. PubMed ID: 28251028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumonia with empyema among children in the first five years of high coverage with 13-valent pneumococcal conjugate vaccine.
    Syrogiannopoulos GA; Michoula AN; Tsimitselis G; Vassiou K; Chryssanthopoulou DC; Grivea IN
    Infect Dis (Lond); 2016 Oct; 48(10):749-53. PubMed ID: 27320108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case report of parapneumonic pleural effusion caused by Streptococcus pneumoniae serotype 19A in a child immunized with 13-valent conjugate pneumococcal vaccine.
    Diawara I; Zerouali K; Elmdaghri N; Abid A
    BMC Pediatr; 2017 Apr; 17(1):114. PubMed ID: 28449653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric Complicated Pneumonia Caused by Streptococcus pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010-2015.
    Silva-Costa C; Brito MJ; Pinho MD; Friães A; Aguiar SI; Ramirez M; Melo-Cristino J; ;
    Emerg Infect Dis; 2018 Jul; 24(7):1307-1314. PubMed ID: 29912700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in Streptococcus pneumoniae serotype 3 associated parapneumonic pleural effusion/empyema after the introduction of PCV13 in Germany.
    Goettler D; Streng A; Kemmling D; Schoen C; von Kries R; Rose MA; van der Linden M; Liese JG
    Vaccine; 2020 Jan; 38(3):570-577. PubMed ID: 31735502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continued Vaccine Breakthrough Cases of Serotype 3 Complicated Pneumonia in Vaccinated Children, Portugal (2016-2019).
    Silva-Costa C; Gomes-Silva J; Pinho MD; Friães A; Ramirez M; Melo-Cristino J
    Microbiol Spectr; 2022 Aug; 10(4):e0107722. PubMed ID: 35862941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complicated pneumococcal pneumonia with pleural effusion or empyema in the 13-valent pneumococcal conjugate vaccine era.
    Díaz-Conradi A; Hernández S; García-García JJ; Muñoz-Almagro C; Moraga-Llop F; Ciruela P; Izquierdo C; Campins M; de Sevilla MF; González-Peris S; Uriona S; Martínez-Osorio J; Solé-Ribalta A; Codina G; Esteva C; Planes AM; Soldevila N; Salleras L; Domínguez A
    Pediatr Pulmonol; 2019 May; 54(5):517-524. PubMed ID: 30784235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Invasive pneumococcal disease in two non-vaccinated pediatric cases: pleural empyema and bacteremia].
    Kanık Yüksek S; Gülhan B; Tezer H; Özkaya Parlakay A; Uzun Kenan B; Sayed Oskovi H; Nar Ötgün S
    Mikrobiyol Bul; 2015 Jul; 49(3):446-53. PubMed ID: 26313286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the 13-valent pneumococcal conjugate vaccine on Streptococcus pneumoniae multiple serotype carriage.
    Valente C; Hinds J; Gould KA; Pinto FR; de Lencastre H; Sá-Leão R
    Vaccine; 2016 Jul; 34(34):4072-8. PubMed ID: 27325351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of a pneumococcal conjugate vaccination program on the nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among healthy children in Turkey.
    Soysal A; Karabağ-Yılmaz E; Kepenekli E; Karaaslan A; Cagan E; Atıcı S; Atınkanat-Gelmez G; Boran P; Merdan S; Hasdemir U; Söyletir G; Bakır M
    Vaccine; 2016 Jul; 34(33):3894-900. PubMed ID: 27269059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing Rates of Pediatric Empyema and Disease Severity With Predominance of Serotype 3 S. pneumonia: An Australian Single-center, Retrospective Cohort 2011 to 2018.
    Haggie S; Fitzgerald DA; Pandit C; Selvadurai H; Robinson P; Gunasekera H; Britton P
    Pediatr Infect Dis J; 2019 Dec; 38(12):e320-e325. PubMed ID: 31634299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
    Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of Streptococcus pneumoniae serotypes that cause parapneumonic empyema in Turkey.
    Ceyhan M; Ozsurekci Y; Gürler N; Ozkan S; Sensoy G; Belet N; Hacimustafaoglu M; Celebi S; Keser M; Dinleyici EC; Alhan E; Baki A; Oner AF; Uzun H; Kurugol Z; Aycan AE; Gurbuz V; Karadag Oncel E; Celik M; Ozkaya Parlakay A
    Clin Vaccine Immunol; 2013 Jul; 20(7):972-6. PubMed ID: 23637041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniae.
    Dagan R; Juergens C; Trammel J; Patterson S; Greenberg D; Givon-Lavi N; Porat N; Gurtman A; Gruber WC; Scott DA
    J Infect Dis; 2015 Apr; 211(7):1144-53. PubMed ID: 25355940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to "Letter to the Editor: Vaccine Failures in Pediatric Cases Caused by Streptococcus pneumoniae Serotype 19A".
    Gönüllü E; Soysal A; Yıldız İ; Aydemir G; Tunç T; Karaböcüoğlu M
    Hum Vaccin Immunother; 2020 Oct; 16(10):2511-2512. PubMed ID: 32750264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotype distribution of Streptococcus pneumoniae in children with invasive diseases in Turkey: 2008-2014.
    Ceyhan M; Ozsurekci Y; Gürler N; Öksüz L; Aydemir S; Ozkan S; Yuksekkaya S; Keser Emiroglu M; Gültekin M; Yaman A; Kiremitci A; Yanık K; Karli A; Ozcinar H; Aydin F; Bayramoglu G; Zer Y; Gulay Z; Gayyurhan ED; Gül M; Özakın C; Güdücüoğlu H; Perçin D; Akpolat N; Ozturk C; Camcıoğlu Y; Karadağ Öncel E; Çelik M; Şanal L; Uslu H
    Hum Vaccin Immunother; 2016; 12(2):308-13. PubMed ID: 26325175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Nuorti JP; Whitney CG;
    MMWR Recomm Rep; 2010 Dec; 59(RR-11):1-18. PubMed ID: 21150868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on serotype 19A invasive pneumococcal disease.
    Principi N; Esposito S
    Expert Rev Vaccines; 2015; 14(10):1359-66. PubMed ID: 26289973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal conjugate vaccination response in patients after community-acquired pneumonia, differences in patients with S. pneumoniae versus other pathogens.
    Wagenvoort GHJ; Vlaminckx BJM; van Kessel DA; Geever RCL; de Jong BAW; Grutters JC; Bos WJW; Meek B; Rijkers GT
    Vaccine; 2017 Sep; 35(37):4886-4895. PubMed ID: 28802755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necrotizing pneumonia and acute purulent pericarditis caused by Streptococcus pneumoniae serotype 19A in a healthy 4-year-old girl after one catch-up dose of 13-valent pneumococcal conjugate vaccine.
    Lu S; Tsai JD; Tsao TF; Liao PF; Sheu JN
    Paediatr Int Child Health; 2016 Aug; 36(3):235-9. PubMed ID: 25936434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.